Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 12, 2011, Pages 1765-1771

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Tada, Toshifumi ^a   Sone, Yasuhiro ^a   Kaneoka, Yuji ^a   Maeda, Atsuyuki ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

After the year 2000; Early detection; Hepatocellular carcinoma; Liver function; Prognosis; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

EID: 81855185448     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06789.x     Document Type: Article

References (22)

1. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2002; 55: 74-108.
2. Befeler AS, DiBisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-19.
3. Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol. Res. 2007; 37: S95-100.
4. Toyoda H, Kumada T, Kiriyama S etal. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Cancer 2004; 100: 2415-21.
5. Toyoda H, Kumada T, Kiriyama S etal. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan. Clin. Gastroenterol. Hepatol. 2006; 4: 1170-6.
6. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
7. Vauthey J-N, Lauwers GY, Esnaola NF etal. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 2002; 20: 1527-36.
8. Kaplan EL, Meier P. Non parametric estimation for incomplete observation. J. Am. Stat. Assoc. 1958; 53: 457-81.
9. Petro R, Pike MC. Conservation of the approximation (0-E2)/E in the log rank test for survival data on tumor incidence data. Biometrics 1973; 29: 579-84.
10. Cox D. Regression models and life tables. J. R. Stat. Soc. 1972; 34: 187-220.
11. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
12. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 2003; 139: 817-23.
13. Tanaka H, Imai Y, Hiramatsu N etal. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann. Intern. Med. 2008; 148: 820-6.
14. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-74.
15. Brechot C, Jaffredo F, Lagorce D etal. Impact of HBV, HCV, and GBV-C/HGV on hepatocellular carcinomas in Europe: results of an European concerted action. J. Hepatol. 1998; 29: 173-83.
16. Kiyosawa K, Sodeyama T, Tanaka E etal. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma. Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
17. Miki D, Aikata H, Uka K etal. Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma. J. Gastroenterol. 2008; 43: 550-7.
18. Shinagawa T, Ohto M, Kimura K etal. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984; 86: 495-502.
19. Takayasu K, Furukawa H, Wakao F etal. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am. J. Roentogenol. 1995; 164: 885-90.
20. Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 1996; 111: 996-1001.
21. Nakao A, Taniguchi K, Inoue S etal. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies. Am. J. Gastroenterol. 1997; 92: 1031-4.
22. Ando E, Kuromatsu R, Tanaka M etal. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J. Clin. Gastroenterol. 2006; 40: 942-8.